130
Views
26
CrossRef citations to date
0
Altmetric
Review

Delivery of parathyroid hormone for the treatment of osteoporosis

Pages 993-1002 | Published online: 04 Nov 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Narges Poursina, Alireza Vatanara, Mohammad Reza Rouini, Kambiz Gilani & Abdolhossein Rouholamini Najafabadi. (2017) Systemic delivery of parathyroid hormone (1–34) using spray freeze-dried inhalable particles. Pharmaceutical Development and Technology 22:6, pages 733-739.
Read now
Herbert Hoyer, Glen Perera & Andreas Bernkop-Schnürch. (2010) Noninvasive delivery systems for peptides and proteins in osteoporosis therapy: a retroperspective. Drug Development and Industrial Pharmacy 36:1, pages 31-44.
Read now
Byron Chalidis, Christopher Tzioupis, Eleftherios Tsiridis & Peter V Giannoudis. (2007) Enhancement of fracture healing with parathyroid hormone: preclinical studies and potential clinical applications. Expert Opinion on Investigational Drugs 16:4, pages 441-449.
Read now

Articles from other publishers (23)

Christopher S. Kovacs & Leanne M. Ward. 2020. Maternal-Fetal and Neonatal Endocrinology. Maternal-Fetal and Neonatal Endocrinology 755 782 .
Subhashis Pal, Konica Porwal, Himalaya Singh, Mohd Yaseen Malik, Mamunur Rashid, Chirag Kulkarni, Yasir Khan, Kumaravelu Jagavelu, Muhammad Wahajuddin & Naibedya Chattopadhyay. (2019) Reversal of Osteopenia in Ovariectomized Rats by Pentoxifylline: Evidence of Osteogenic and Osteo-Angiogenic Roles of the Drug. Calcified Tissue International 105:3, pages 294-307.
Crossref
Seung-Ju Kim, Hyun-Soo Park, Dong-Woo Lee & Jae-Won Lee. (2019) Short-term daily teriparatide improve postoperative functional outcome and fracture healing in unstable intertrochanteric fractures. Injury 50:7, pages 1364-1370.
Crossref
Subhashis Pal, Konica Porwal, Kunal Khanna, Manoj Kumar Gautam, Mohd Yaseen Malik, Mamunur Rashid, R. John Macleod, Muhammad Wahajuddin, Venkitanarayanan Parameswaran, Jayesh R. Bellare & Naibedya Chattopadhyay. (2019) Oral dosing of pentoxifylline, a pan-phosphodiesterase inhibitor restores bone mass and quality in osteopenic rabbits by an osteogenic mechanism: A comparative study with human parathyroid hormone. Bone 123, pages 28-38.
Crossref
Robert Brommage. 2020. Bone Regulators and Osteoporosis Therapy. Bone Regulators and Osteoporosis Therapy 451 473 .
Seung-Ju Kim, Hyun-Soo Park, Dong-Woo Lee & Jae-Won Lee. (2018) Does short-term weekly teriparatide improve healing in unstable intertrochanteric fractures?. Journal of Orthopaedic Surgery 26:3, pages 230949901880248.
Crossref
Zhigao Niu, Inmaculada Conejos-Sánchez, Brendan T. Griffin, Caitriona M. O’Driscoll & María J. Alonso. (2016) Lipid-based nanocarriers for oral peptide delivery. Advanced Drug Delivery Reviews 106, pages 337-354.
Crossref
Giovanna Della Porta, Roberta Campardelli, Vincenzo Cricchio, Francesco Oliva, Nicola Maffulli & Ernesto Reverchon. (2016) Injectable PLGA/Hydroxyapatite/Chitosan Microcapsules Produced by Supercritical Emulsion Extraction Technology: An In Vitro Study on Teriparatide/Gentamicin Controlled Release. Journal of Pharmaceutical Sciences 105:7, pages 2164-2172.
Crossref
T. J. S. ChesserR. FoxK. HardingR. HallidayS. BarnfieldK. WillettS. LambC. YauM. K. JavaidA. C. GrayJ. YoungH. Taylor, K. ShahR. Greenwood. (2016) The administration of intermittent parathyroid hormone affects functional recovery from trochanteric fractured neck of femur. The Bone & Joint Journal 98-B:6, pages 840-845.
Crossref
Ali Aghazadeh-Habashi, Yang Yang, Kathy Tang, Raimar Lőbenberg & Michael R. Doschak. (2015) Transdermal drug delivery: feasibility for treatment of superficial bone stress fractures. Drug Delivery and Translational Research 5:6, pages 540-551.
Crossref
BT Griffin & CM O’Driscoll. (2011) Opportunities and challenges for oral delivery of hydrophobic versus hydrophilic peptide and protein-like drugs using lipid-based technologies. Therapeutic Delivery 2:12, pages 1633-1653.
Crossref
Markus R. John, Leo Widler, Rainer Gamse, Thomas Buhl, Klaus Seuwen, Werner Breitenstein, Gerard J.M. Bruin, Rossella Belleli, Lloyd B. Klickstein & Michaela Kneissel. (2011) ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans. Bone 49:2, pages 233-241.
Crossref
Leo Widler. (2011) Calcilytics: antagonists of the calcium-sensing receptor for the treatment of osteoporosis. Future Medicinal Chemistry 3:5, pages 535-547.
Crossref
Aasis Unnanuntana, Roberto Miki, Brian P. Gladnick, Pamela J. Sherman, Gigi R. Madore & Joseph M. Lane. 2011. Rothman Simeone The Spine. Rothman Simeone The Spine 1571 1595 .
Masaya Etoh & Akira Yamaguchi. (2010) Repetition of continuous PTH treatments followed by periodic withdrawals exerts anabolic effects on rat bone. Journal of Bone and Mineral Metabolism 28:6, pages 641-649.
Crossref
Remigius U Agu, Dominic U Obimah, Wendy J Lyzenga, Mark Jorissen, Emad Massoud & Norbert Verbeke. (2009) Specific aminopeptidases of excised human nasal epithelium and primary culture: a comparison of functional characteristics and gene transcripts expression. Journal of Pharmacy and Pharmacology 61:5, pages 599-606.
Crossref
Johannes D. Veldhuis, Daniel M. Keenan & Steven M. Pincus. (2008) Motivations and Methods for Analyzing Pulsatile Hormone Secretion. Endocrine Reviews 29:7, pages 823-864.
Crossref
Laura Gehrig, Joseph Lane & Mary I. OʼConnor. (2008) Osteoporosis. The Journal of Bone & Joint Surgery 90:6, pages 1362-1374.
Crossref
Edward F Nemeth. (2008) Anabolic therapy for osteoporosis: Calcilytics. IBMS BoneKEy 5:6, pages 196-208.
Crossref
David A. Hanley, Patricia H. Watson, Anthony B. Hodsman & David W. Dempster. 2008. Principles of Bone Biology. Principles of Bone Biology 1659 1695 .
J. D. Veldhuis. 2008. Ultradian Rhythms from Molecules to Mind. Ultradian Rhythms from Molecules to Mind 229 248 .
Marit D Moen & Lesley J Scott. (2007) Recombinant Full-Length Parathyroid Hormone (1-84)1. BioDrugs 21:3, pages 205-208.
Crossref
James Whitfield. (2006) Recombinant Full-Length Parathyroid Hormone (1-84). Drugs 66:18, pages 2382-2385.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.